7th Sep 2010 08:44
Veterinary products group Dechra Pharmaceuticals posted a 10% rise in annual profit and hiked its dividend 18% as demand for its products strengthened. Pre-tax profit rose to £17.7m in the year ended 30 June 2010 from £16.1m the year before. Revenue increased 5.5% to £369.4m. "We have increased in
Read more7th Jul 2010 16:00
Dow Jones smallcap news is on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps PHOTO-ME INTERNATIONAL PLC (PHTM.LN), a photo booth operator, said a significant proportion of future revenue is set to come from its "futuristic" photo boot
Read more7th Jul 2010 13:39
(Adds detail and analyst comment.) By Jason Douglas Of DOW JONES NEWSWIRES LONDON (Dow Jones)--Veterinary pharmaceuticals company Dechra Pharmaceuticals PLC (DPH.LN) Wednesday said fiscal-year revenue was 5.3% higher on year, driven by rising sales in the U.S. Stoke-on-Trent, England
Read more7th Jul 2010 07:34
LONDON (Dow Jones)--Dechra Pharmaceuticals PLC (DPH.LN), announced Wednesday for the year ended June 30, Group revenue was 5.3% ahead of the equivalent period last year and the Group continues to perform robustly and in line with management views. MAIN FACTS: -The company remains confident a
Read more7th May 2010 06:54
Is BP going to go bankrupt? That is the question for investors and putative investors to answer. Certainly the immediate outlook is bad. The fatal explosion and subsequent sinking of the Deepwater Horizon rig in the Gulf of Mexico two weeks ago is an unmitigated disaster. But chief executive Tony H
Read more23rd Feb 2010 16:21
A terrible report on US consumer confidence sent Wall Street spiralling lower, dragging London's leading index deep into the red late on. UK shares started well enough, but weakened steadily through the morning and spent much of the afternoon dipping in and out of negative territory until the US da
Read more23rd Feb 2010 15:16
A weak opening on Wall Street has dragged Footsie lower, though the number of fallers among the blue-chip index's constituents barely outnumbers the risers. Wolseley is leading the risers, after surprising the market with an unscheduled trading update. The building supplies group said it expects p
Read more23rd Feb 2010 12:13
For the second day in succession the FTSE 100 has turned lower after a moderately bright start. Comments on the fragility of the UK economy from Bank of England governor Mervyn King have given investors pause for thought. King, appearing before a parliamentary committee, said: 'There have been some
Read more23rd Feb 2010 08:38
Shares have started strongly as company updates are given a warm reception. Shares in Wolseley jumped after the building supplies group said it expects profits for the year to 31 July 2010 to exceed analysts' expectations of £326m. However, it said the better than expected earnings will be due to
Read more23rd Feb 2010 07:54
Veterinary products group Dechra Pharmaceuticals reported a rise in profits in the six months to December 31 as it continued growing sales in spite of the economic downturn. Pre-tax profits rose to £9.7m from £7.3m on revenues that climbed to £184.8m from £173.2m. The main part of the business, se
Read more22nd Feb 2010 17:20
Drax, operator of the UK's largest coal-fired power station, is set to report a sharp drop in full year pre-tax profits on Tuesday, with the investment analyst community expecting a figure of around £266.1m, compared to £442.5m in 2008. Revenue is expected to ease to £1,356.0m from £1,752.8m. Full
Read more13th Jan 2010 06:36
Tesco is leagues ahead of its UK competition in terms of global reach, scale and ambition. In fact, it is the only UK supermarket with any overseas operations at all, and one of just a few British retailers with international stores. The stock trades on a 2011 price earnings ratio of 13.2 times.
Read more12th Jan 2010 08:55
Veterinary-focused drug group Dechra Pharmaceuticals posted a 6.5% year-on-year rise in sales in the six months to December 31 and said it was seeing signs of volume growth returning to the market. The pharmaceuticals division saw sales growth of 12.6%, while the services division's revenues were u
Read more17th Dec 2009 07:58
Dechra Pharmaceuticals is beefing up its board with the appointment of industry veteran Bryan Morton as a non-executive director. Morton has been in the pharmaceuticals industry for 30 years, spending most of his career with Merck and Bristol Myers Squibb. He is currently President and Chief Execu
Read more6th Nov 2009 17:15
The Footsie finished a see-saw day in positive territory, shrugging off concerns about the worse than expected US jobless figures, which revealed the US unemployment rate has risen above the 10% level. Banks enjoyed a day in the sun, helped by a positive response to results from Royal Bank of Scotl
Read more